Published 2010 | Version v1
Publication

A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer

Citation

An error occurred while generating the citation.

Additional details

Created:
April 14, 2023
Modified:
November 28, 2023